Multi-modal antidepressant-like action of 6- and 7-chloro-2-aminodihydroquinazolines in the mouse tail suspension test

Psychopharmacology
Kavita A IyerMalgorzata Dukat

Abstract

2-Amino-6-chloro-3,4-dihydroquinazoline (e.g., A6CDQ) represents a novel putative antidepressant originally thought to act through a 5-HT3 serotonin receptor antagonist mechanism. Here, we investigated this further by examining a positional isomer of A6CDQ (i.e., A7CDQ). 5-HT3 receptor and transporter activity (uptake-1 and uptake-2) were investigated using a variety of in vitro assays and the in vivo mouse tail suspension test (TST). Although A7CDQ binds at 5-HT3 receptors with low affinity (Ki = 1975 nM) compared to A6CDQ (Ki = 80 nM), it retained 5-HT3 receptor antagonist action (IC50 = 5.77 and 0.26 μM, respectively). In the mouse TST A7CDQ produced antidepressant-like actions (ED50 = 0.09 mg/kg) comparable to that of A6CDQ. In addition, A6CDQ was found to be a 5-HT releasing agent (Km = 2.8 μM) at hSERT and a reuptake inhibitor (IC50 = 1.8 μM) at hNET, whereas A7CDQ was a weak reuptake inhibitor (Km = 43.6 μM) at SERT but a releasing agent (EC50 = 3.3 μM) at hNET. Moreover, A6CDQ and A7CDQ were potent inhibitors of uptake-2 (e.g.; OCT3 IC50 = 3.9 and 5.9 μM, respectively). A simple shift of a substituent in a common quinazoline scaffold from one position to another (i.e., a chloro group from the 6- to the 7-position) resul...Continue Reading

References

Oct 27, 1998·Stress : the International Journal on the Biology of Stress·D Marona-Lewicka, D E Nichols
Jul 12, 2002·British Journal of Pharmacology·Martina Hayer-ZillgenHeinz Bönisch
Aug 7, 2002·Pharmacology & Therapeutics·Richard B Rothman, Michael H Baumann
Nov 15, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Frank P BymasterKenneth W Perry
Nov 13, 2003·European Journal of Pharmacology·Richard B Rothman, Michael H Baumann
Dec 4, 2003·Molecular Psychiatry·B EisensamerR Rupprecht
Sep 29, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hideki IwamotoLouis J De Felice
Feb 4, 2010·Journal of Psychopharmacology·Ramamoorthy Rajkumar, Radhakrishnan Mahesh
Feb 24, 2011·Current Opinion in Pharmacology·Paul A Davies
Oct 22, 2011·British Journal of Pharmacology·Aldo A Rodriguez-MenchacaLouis J De Felice
Feb 1, 2012·The Journal of Biological Chemistry·Ernesto SolisLouis J De Felice
Mar 16, 2013·British Journal of Pharmacology·A J Thompson, S C R Lummis
Sep 17, 2013·Bioorganic & Medicinal Chemistry Letters·Małgorzata DukatMarvin K Schulte
Dec 1, 2004·Drug Discovery Today. Technologies·Christopher A Lipinski
May 23, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ernesto SolisMichael H Baumann
Aug 16, 2017·Bioorganic & Medicinal Chemistry Letters·Xiaolei PanMałgorzata Dukat
Feb 27, 2018·Neuropharmacology·Blanca Perez-PalomarJorge E Ortega

❮ Previous
Next ❯

Citations

Mar 19, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Katharigatta N VenugopalaViresh Mohanlall

❮ Previous
Next ❯

Methods Mentioned

BETA
transfections
transfecting
fluorescence imaging
fluorescence microscopy

Software Mentioned

pCLAMP
Prism
GraphPad
Till Photonics
GraphPad Prism
Origin
Clustal Omega

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.